Trading Signals: SGMO Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 13, 2022)(Sangamo Therapeutics, Inc. )
| SGMO latest price $9.7000 (0.21%) ($9.5800 - $9.9600) on Wed. Nov. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.64% (three month average) | RSI | 64 | Latest Price | $9.7000(0.21%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGMO advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support SGMO advance at 0% a week (0% probability) XBI(63%) ARKG(59%) ARKK(53%) IBB(53%) IWO(51%) | Factors Impacting SGMO price | SGMO will decline at least -1.32% in a week (0% probabilities). VXX(-31%) VIXM(-29%) TLT(-8%) UUP(1%) UNG(4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.32% (StdDev 2.64%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $9.52(1.89%) | 10 Day Moving Average | $9.59(1.15%) | 20 Day Moving Average | $9.41(3.08%) | To recent high | -15.7% | To recent low | 20.8% | Market Cap | $1.125b | | | | Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA. |